Our current issue is located at,
http://www.research.ucla.edu/whatsbruin/2004/7/



 
   
 
   

ISSUE No. 6 | NEWSLETTER | SPRING, 2002
In this Issue:
 Startup Initiative at UCLA Starts Up [more]
 The Next 50 years - Research at UCLA School of Medicine [more]
 New Grant $$ Available for UCLA-Industry Research Collaborations [more]
 Venture Funding Announcements (UCLA faculty affiliated companies) [more]
 Industry Mixer & Research Review Events at UCLA [more]
Wireless Internet | Comp Sci | AINS | Electrical Eng | Mech/Aero Eng
 Spotlighting New Research Programs at UCLA [more]
 News From the Labs [more]
 Recently Issued Patents (selected) [more]
 
About This Newsletter [more]

UCLA Startup Initiative Starts Up
UCLA faculty researchers pack seminar to learn how to do a startup without leaving their day job

Academic institutions well-known in the business community for launching startups based on faculty research generally include the likes of Stanford, MIT and Caltech, but rarely UCLA.

New initiatives underway at UCLA may change that perception sooner than later based on the attendance and feedback from the recent UCLA Faculty Startup Seminar held on campus, March 20, 2002.

The UCLA Faculty Startup Seminar, conceived and hosted by the UCLA Office of Intellectual Property and Concept2Company, Inc., a Silicon Valley venture firm specializing in university startups, is the first in a series of seminars designed to address the unique needs of faculty entrepreneurs at UCLA.

The Seminar brought together leading faculty researchers and successful entrepreneurs to share anecdotal startup stories, how-to/how-not-to advice, policy concerns, and touched on potential business models for transferring university technology to new startups. Additional information about the March 20 Seminar - panel, topics, speakers, etc. - is located here: http://www.research.ucla.edu/oipa/seminar. The 2nd UCLA Faculty Startup Seminar in the series will be held later this year.

Other venture-related initiatives at UCLA seek to facilitate the networking, education and team building required to transfer technology successfully to startups.

Contact for the Faculty Startup Seminar series, and new venture-related initiatives at UCLA is:

David Lundberg, Ph.D.
Director of Strategic Alliances, OIPA
dlundberg@support.ucla.edu

The Next 50 Years - Research at the School of Medicine
Predictions from UCLA School of Medicine Faculty

The latest issue of UCLA Medicine magazine features several predictions from leading UCLA School of Medicine faculty researchers on what changes the next 50 years will bring to their fields.

Research areas mentioned include: Imaging; Transplantation; Managed Care; Voice Recognition; Radiation Oncology; Aids Vaccine; Biochemistry; Stem Cell Therapies; and Genetic Information.
[VIEW FULL ARTICLE]

And, capturing even more insight into the UCLA School of Medicine's ongoing research is an in-depth UCLA Medicine magazine interview, "An Era of Extraordinary Progress," with, Dr. Leonard Rome, Associate Vice Chancellor for Research.
[VIEW FULL ARTICLE]

New Grant $ Available for UCLA-Industry Collaborations
What exactly is available? how much? current deadlines? does your company qualify?


The University of California's Industry-University Cooperative Research Program (IUCRP) is comprised of six research partnership programs that join California businesses and UC researchers in efforts to accelerate early stage research needed to create next generation technologies and products.

The sector programs are listed below with links, and accept research proposals three times a year using an online proposal submission system.

The IUCRP is now responsible for up to $60 million per year in matched funding from the State of California, Industry and the University of California, and has already invested more than $100 million in research partnerships. (see funded projects.)

Businesses with relevant R&D operations in California are generally eligible for IUCRP.

The Sector Programs (with deadlines) are:

(4/23/02) BioStar—biotechnology
(4/30/02) CoRe—communications and networking research
(5/21/02) DiMI—digital media innovation
(5/14/02) LS:IT—life sciences & information technology
(n/a) MICRO—microelectronics innovation
(5/07/02) SMART—electronics manufacturing

Venture Funding Announcements
UCLA faculty-affiliated companies announce venture capital/investment funding rounds.

  • Agensys, Inc. — company develops targeted cancer therapeutics based on novel, clinically relevant antigen discoveries.
    Amount: $42 Million
    Type: Private Placement
    Date: 3/11/02
    Company Press Release

    Affiliated UCLA Faculty Member: Dr. Arie Belldegrun

  • Nanosys, Inc.— company is focused on the development of nanotechnology-enabled systems.
    Amount: $15 million
    Type: Series B Financing
    Date: 2/02
    Company Press Release

    Affiliated UCLA Faculty Member: Dr. James Heath


  • Luxtera, Inc. — company is developing breakthrough photonics products.
    Amount: $7 million
    Type: Series A
    Date: 1/31/02
    Related Article

    Affiliated UCLA Faculty Member: Dr. Eli Yablonovitch


    Industry Mixer Events at UCLA
    Upcoming industry meetings and research & technology reviews

    April 26, 2002
    Computer Science Department Research Review
    Future of web technology, computer animation and embedded networked sensing are among the topics that will be discussed at UCLA's Computer Science Review—Throughout the day and at an evening banquet, participants can learn more about the department's research and discuss opportunities to collaborate with its faculty and graduate students.

    May 6-7, 2002
    2nd Annual Wireless Internet Conference
    Covers vital topics and technologies essential for the development of business models and platforms in the wireless sector. Key wireless
    industry leaders, researchers and executive-level attendees discuss how innovations in mobile technology will impact enterprises and businesses. Henry Samueli (Broadcomm founder and former UCLA EE professor) is keynote speaker.

    May 8-9, 2002
    1st Annual Autonomous Intelligent Networks and Systems
    This Symposium will explore research issues in the area of Autonomous Intelligent Networks and Systems (AINS) with applications in several disciplines including Communications Systems, Controls, Wireless Self-configuring Ad Hoc Networks, Battlefield Networks, Biologic Systems and related areas.

    AINS serves as a forum for intelligent agent technologists and visionaries from academia, industry and research labs, to present current research, advanced technology, ongoing prototyping efforts, experience reports, case studies, and descriptions of interesting systems.

    May 10, 2002
    Mechanical and Aerospace Engineering Research and Technology Review
    The event serves to both present the accomplishments of the MAE Faculty and students and to create close ties between them and the local engineering industry.

    Research areas include:  MEMS in biological and Eng. Systems; Active Composite Materials; Power Systems; Dynamics and Control Systems; Aerodynamics and Rocket engine Systems; Micro- and Nano-scale materials fabrication; and Battle Management fabrication

    October 21, 2002
    Electrical Engineering Department Research Review
    Graduate students present their latest research results and answer questions from industrial and government sponsors; attending guests gain advanced access to new and groundbreaking research. The many fields of the department are loosely grouped into the following three areas: Signals and Systems, Circuits and Embedded Systems, and Physical Electronics.

    Spotlight—New Research Programs at UCLA
    Introducing major research programs and initiatives at UCLA

  • NEW BIOTECH RESEARCH/CURRICULUM LABS
    UCLA researchers have extended their expertise in MEMS to developing even smaller devices at the nano level, "Bio-NEMs."

    Professors Chih-Ming Ho, C.J. Kim (Mech. & Aero. Eng.) and Robin Garrell (Biochemistry) recently received $400,000 from Intel Corporation to establish new biotech research/curriculum laboratories at UCLA.

    The new Bio-NEMS curriculum (begins this Fall) and research labs will train Engineers, Doctors and others to design bio-signature devices, which have a number of potential uses in the healthcare industry, including diagnosis of bacterial infections, detection of the onset of a disease and detection of bacterial contamination in food. MORE

  • CANCER THERAPY DEVELOPMENT PROGRAM
    The latest clinical research programs at UCLA in cancer prevention and treatment are described in detail here.

    To learn about additional research program areas at the Jonsson Comprehensive Cancer Center (including Signal Transduction, Tumor Immunology, and Gene Regulation), visit this webpage.

  • DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY
    An overview of the emerging research areas in UCLA's Dept. of Chem/Biochem is is located here. These fields include theoretical chemistry, chemical biology, exotic materials, structural biology and proteomics, and supple electronics.

  • News from the Labs
    A link synopsis of articles and press releases mentioning the latest research coming out of UCLA labs. Click here for Today's news.

  • Unlocking Secrets of Plasma [more]
  • Fiber Optics, as Never Been Seen [more]
  • UCLA Receives $4.8 Million Grant to Support Research in World's Best Plasma Physics Facility [more]
  • UCLA Neurologist Awarded $6 Million to Search for Autism Genes [more]
  • UCLA Molecular Biologists Unravel Mysteries of 'Factory of Life' [more]
  • UCLA-Led Team Creates Self-Repairing Plastic [more]
  • MEMS Could Help Blind See, UCLA Scientist Tells Conference [more] Inventor's lab:[more]
  • Molecular Motors Could Help Research [more]
  • Brain Defects in Schizophrenia Patients Identified by UCLA Scientists [more]
  • UCLA Team Maps How Genes Affect Brain Structure, Intelligence: Dramatic Images Shed Light on Brain Diseases, Personality Differences [more]
  • UCLA Scientists Identify Genetic Link to Migraine [more]
  • California Healthline, a publication of the California healthcare Foundation, published a feature on the Global Care Quest software package developed by UCLA's Division of Neurosurgery. The software allows physicians to access a wealth of patient information via wireless handheld computers. Co-developers Dr. Neil Martin, professor of neurosurgery chief of the division, and Val Nenov, an associate professor of neurosurgery, commented in the article.
    "Physicians Online with New Handheld Devices"
  • UCLA Researchers Encouraged by Results of Stroke Pilot Study [more]
  • Computers With 'Dynamic Vision' Could Become Virtual Surgeons [more]
  • UCLA Scientists Identify Origin for Learning Problems in Genetic Disease, NF1; Will Lead to New Treatments for Other Learning Disabilities [more]
  • UCLA Researchers Invent First Technique to Image Alzheimer's Onset; Findings Will Speed Diagnosis, Intervention and New Therapies [more]
  • Brain PET Scan Predicts if Memory Lapses Will Progress Into Dementia, Detects Alzheimer's Disease at Earliest Stage, UCLA-Led Study Finds [more]
  • Tiny, Wireless MEMS Sensors Could Find Terrorists Hiding in Caves of Afghanistan or Underground Bunkers [more]
  • Scientists at UCLA's Jonsson Cancer Center Discover Gene's Role in Regulating Stem Cells in the Brain [more]

    Recently Issued Patents - UCLA Faculty
    A selected listing of issued patents with a link to each patent's first page information.

  • Gaba alpha receptors mediate inhibition of T cell responses [more]
  • Detection of copy number changes in colon cancer [more]
  • Gangliosides with immunosuppressive activity [more]
  • Transcriptionally regulated G protein-coupled receptor [more]


  • Synthesis of perhydroxydodecaborate salts and related species [more]
  • Molecular-wire crossbar interconnect (MWCI) for signal routing and communications [more]
  • Adaptive multiplexing/demultiplexing method and multiplexer/demultiplexer therefor [more]


  • Leafy cotyledon1 genes and their uses [more]
  • IBD-associated microbial antigens and methods of using same [more]
  • Secretory immunoglobulin produced by single cells and methods for making and using same [more]
  • Genetic marker test for lupus [more]
  • Latest Technologies Available for Licensing

    For Complete Listing
    Latest Disclosures:
  • High-Performance Polymer Photovoltaic Device 2002-317
  • Optoelectronic Nanowire Chemical Sensors 2002-273
  • Coated Filter for Growing Reusable Organotypic Tissue Slices 2002-222


  • Retrocyclin: an Antiviral Circular Minidefensin 2001-329
  • Novel Treatment of Asthma, Allergic Diseases, and COPD 2001-482
  • C-MYC Transgenic Mouse 2002-135
  • A Method for Inducing MHC Class-II Restricted CD4+ T Cells 2002-272
  • Reverse Transcriptase-Mediated Tropism Switching in Bodetella Bacteriophage 2002-166

  • Multimedia Features
  • California Nobel Prize Centennial Celebration [more]
  • Imaging the Living Biology of Our Bodies in Health and Disease [more]


    Homer in the 21st Century

    UCLA's Hypermedia Lab is combining technology, media and theater to retell one of the oldest stories in Western literature, Homer's "Iliad."

    Digital media artist and professor of film, Fabian Wagmister, leads the group in experimenting with advanced sensing technologies, distributed networks, show control, automated production systems and digital multimedia software to discover a new performance process with a new artistic result on a classic literary piece.

    Wired article
    UCLA Press Release

  •   
     Techs Available Cont...
  • Use of a Gene and Related Mouse Model for the Study and Development of Therapeutics for Neuropsychiatric Disorders 2002-133
  • Electronics Integrated with Bio-Reactor Channel For Detection or Fabrication of Bio-Materials 2000-499

    BioDetection
    Technologies
    Cluster

  • Nanoparticle Chain Aggregates: A New State of Matter 2001-247
  • Directionally Oriented Particle Composites 2002-265

    Autoimmunity
    Technologies
    Cluster

  • Anti-sense Oligonucleotide Targeted Prophylactic and Chemotherpeutic Agent Against Mycobacterium Tuberculosis 2000-203
  • Gene Therapy for Corneal Dystrophies 2002-219
  • Gene Therapy for Age-Related Macular Degeneration 2002-220



  • Diagnostic Phenotype Assay for Engineered Cells and Tissues 2001-285
  • TCL1 Transgenic Mice with Altered Immune System Function 2002-274
  • Diagnostic and Therapeutic Potential of Na, K-ATpase Beta-Subunit in Cancer 2002-207
  • Membrane Estrogen Receptor-Directed Therapy in Breast Cancer 2000-081

  • Community SideBar
    LARTA has announced the new schedule for CalTIP proposal submissions (5/15/02).

    CalTIP is a California venture fund focused on turning cutting-edge technologies into commercial products and services.

    For more information, visit, LARTA.org

      
    Did You Know?
    UCLA Faculty Researchers were awarded more than $655,000,000 in research funding during FY 2000-2001.

    Annual Report
      

     

     

     
    Archived Issues
      

     
       About,  What's BRUIN in the Labs?
     
    Published by:
    UCLA Office of Intellectual Property (OIPA)

    Managing Editor/Contact:
    Bob Nidever, OIPA
    bnidever@ucla.edu
    310-794-0558

    How to Subscribe:
    Send "subscribe" message to: research@ucla.edu

    Mailing Address:
    UCLA Office Of Intellectual Property
    10920 Wilshire Blvd., Suite 1200
    Los Angeles, CA 90024
    310-794-0558

    Additional Information:
    Please visit, http://www.whatsBruin.com

    What's BRUIN

    in the Labs?
    Copyright 2002 Regents of the University of California